Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) analyst actions
Rating and price-target actions on ADAP in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ADAP overview →
No ADAP analyst action events in the measured window.
Nothing matched in the current window — the ADAP overview has every event we measure for this name.
Get an email when ADAP moves on news →Keep exploring
More ADAP: earnings → · SEC filings → · ADAP overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Zomedica Corp. Common Shares (ZOM) | 161 | +0.08% | 53% |
| AVITA MEDICAL (AVMXY) | 160 | 0.00% | 46% |
| DURECT Corporation (DRRX) | 159 | +0.03% | 51% |
| Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) | 159 | -1.80% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.